Maladies peptiques [Progress in 2008 for acid related diseases]

Details

Ressource 1Download: RMS_idPAS_D_ISBN_pu2009-03s_sa02_art02.pdf (294.52 [Ko])
State: Public
Version: Final published version
License: CC BY-NC-ND 4.0
Serval ID
serval:BIB_46E5D698B7F2
Type
Article: article from journal or magazin.
Publication sub-type
Review (review): journal as complete as possible of one specific subject, written based on exhaustive analyses from published work.
Collection
Publications
Institution
Title
Maladies peptiques [Progress in 2008 for acid related diseases]
Journal
Revue medicale suisse
Author(s)
Jornod P., Vouillamoz D., Viani F., Nichita C., Dorta G.
ISSN
1660-9379 (Print)
ISSN-L
1660-9379
Publication state
Published
Issued date
21/01/2009
Peer-reviewed
Oui
Volume
5
Number
187
Pages
167-170,172-175
Language
french
Notes
Publication types: English Abstract ; Journal Article
Publication Status: ppublish
Abstract
The treatment of reflux disease did not change in the review period. PPI therapy remains the first line treatment and surgery the second line approach. Endoscopic anti-reflux procedures should be only performed in controlled studies. Beside the classic triple therapy, sequential treatment of Helicobacter pylori infection can today be considered as a first line therapy. PPI are effective in the prevention of gastroduodenal lesions and in the treatment of dyspeptic symptoms induced by NSAIDs treatment. Only patients younger then 65 years and without any risk factors do not need a preventive PPI prescription during classic NSAIDS treatment.
Keywords
Anti-Ulcer Agents/therapeutic use, Digestive System Surgical Procedures, Gastroesophageal Reflux/therapy, Helicobacter Infections/drug therapy, Humans, Proton Pump Inhibitors/therapeutic use
Pubmed
Create date
17/04/2009 18:08
Last modification date
03/12/2024 7:12
Usage data